Dashboard
1
High Management Efficiency with a high ROE of 17.43%
2
Company has very low debt and has enough cash to service the debt requirements
3
Healthy long term growth as Net Sales has grown by an annual rate of 18.15%
4
Flat results in Jun 25
5
With ROE of 8.73%, it has a Attractive valuation with a 0.20 Price to Book Value
6
Market Beating performance in long term as well as near term
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
2.76%
0%
2.76%
6 Months
-4.7%
0%
-4.7%
1 Year
58.16%
0%
58.16%
2 Years
76.98%
0%
76.98%
3 Years
132.29%
0%
132.29%
4 Years
93.91%
0%
93.91%
5 Years
67.67%
0%
67.67%
Jilin Province Huinan Changlong Bio Pharmacy Co. Ltd. for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
18.15%
EBIT Growth (5y)
21.33%
EBIT to Interest (avg)
100.00
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.29
Sales to Capital Employed (avg)
0.43
Tax Ratio
14.72%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
27.76%
ROE (avg)
17.43%
Valuation key factors
Factor
Value
P/E Ratio
2
Industry P/E
Price to Book Value
0.20
EV to EBIT
-2.08
EV to EBITDA
-1.96
EV to Capital Employed
-0.32
EV to Sales
-0.48
PEG Ratio
0.16
Dividend Yield
37.13%
ROCE (Latest)
Negative Capital Employed
ROE (Latest)
8.73%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Bullish
RSI
No Signal
Bearish
Bollinger Bands
Sideways
Bullish
Moving Averages
Bullish (Daily)
KST
Mildly Bearish
Bullish
Dow Theory
Mildly Bullish
Mildly Bullish
OBV
Mildly Bearish
Mildly Bearish
Shareholding Snapshot
No data for shareholding present.
Shareholding Compare (%holding) 
No data for shareholding present.
Quarterly Results Snapshot (Consolidated) - Dec'16 - YoY
Dec'16
Dec'15
Change(%)
Net Sales
205.10
170.00
20.65%
Operating Profit (PBDIT) excl Other Income
65.30
47.30
38.05%
Interest
0.10
0.00
Exceptional Items
0.00
0.00
Consolidate Net Profit
61.70
45.00
37.11%
Operating Profit Margin (Excl OI)
297.10%
265.40%
3.17%
USD in Million.
Net Sales
YoY Growth in quarter ended Dec 2016 is 20.65% vs -39.82% in Dec 2015
Consolidated Net Profit
YoY Growth in quarter ended Dec 2016 is 37.11% vs -38.02% in Dec 2015
Annual Results Snapshot (Consolidated) - Dec'24
Dec'24
Dec'23
Change(%)
Net Sales
955.40
929.90
2.74%
Operating Profit (PBDIT) excl Other Income
205.70
179.70
14.47%
Interest
2.20
0.60
266.67%
Exceptional Items
6.30
-0.40
1,675.00%
Consolidate Net Profit
199.80
163.80
21.98%
Operating Profit Margin (Excl OI)
184.50%
160.50%
2.40%
USD in Million.
Net Sales
YoY Growth in year ended Dec 2024 is 2.74% vs -4.99% in Dec 2023
Consolidated Net Profit
YoY Growth in year ended Dec 2024 is 21.98% vs -27.23% in Dec 2023
About Jilin Province Huinan Changlong Bio Pharmacy Co. Ltd. 
Jilin Province Huinan Changlong Bio Pharmacy Co. Ltd.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates 
No Company Details Available






